Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

SRx Health Solutions (SRXH) Net Cash Flow (2016 - 2025)

SRx Health Solutions' Net Cash Flow history spans 14 years, with the latest figure at $690000.0 for Q2 2025.

For Q2 2025, Net Cash Flow rose 2016.67% year-over-year to $690000.0; the TTM value through Sep 2025 reached -$634000.0, down 142.55%, while the annual FY2023 figure was -$5.0 million, 74.23% up from the prior year.
Net Cash Flow reached $690000.0 in Q2 2025 per SRXH's latest filing, up from -$1.9 million in the prior quarter.
In the past five years, Net Cash Flow ranged from a high of $30.7 million in Q3 2021 to a low of -$5.6 million in Q2 2022.
Average Net Cash Flow over 5 years is $37055.6, with a median of -$1.1 million recorded in 2023.
Peak YoY movement for Net Cash Flow: soared 2284.5% in 2021, then plummeted 1584.95% in 2022.
A 5-year view of Net Cash Flow shows it stood at -$4.3 million in 2021, then grew by 27.25% to -$3.1 million in 2022, then surged by 120.85% to $655000.0 in 2023, then dropped by 7.63% to $605000.0 in 2024, then rose by 14.05% to $690000.0 in 2025.
Per Business Quant, the three most recent readings for SRXH's Net Cash Flow are $690000.0 (Q2 2025), -$1.9 million (Q1 2025), and $605000.0 (Q4 2024).